VitMode

Long COVID: Symptoms and Treatment — What Do We Actually Know?

Several years after the peak of the pandemic, long COVID (the persistent aftereffects of COVID-19) still affects a meaningful share of people who've had the infection — from chronic fatigue, through "brain fog," to breathlessness lasting for months. Despite hundreds of identified symptoms, there's still no single approved drug targeted at this condition. We explain the official definition, the most common symptoms according to large analyses, and what currently actually has evidence support in management, and what remains at the research stage.

AKdr Anna KowalczykSeptember 21, 202614 min read
Table of contents

What long COVID formally is

The World Health Organization defines post-COVID-19 condition (commonly called long COVID) as a set of symptoms occurring in people with a confirmed or probable past SARS-CoV-2 infection, usually present around 3 months from the onset of illness, persisting for at least 2 months, and not explained by an alternative diagnosis. This is deliberately a broad, functional definition — not one specific symptom, just a time frame and a criterion of excluding other causes, which reflects how heterogeneous this clinical picture is.

This heterogeneity is one of the main reasons long COVID remains difficult to study and treat: different patients present very different combinations of symptoms, with different likely mechanisms, under one shared diagnostic label. This situation resembles other symptom clusters with unclear, multifactorial pathophysiology, where simply naming the problem doesn't yet mean understanding its mechanism or having one universal therapy.

How common the problem is — what a large meta-analysis shows

Global Prevalence of Long COVID, Its Subtypes, and Risk Factors: An Updated Systematic Review and Meta-analysis

Moderate evidence

Hou Y, Gu T, Ni Z, Shi X, Ranney ML, Mukherjee B · Open Forum Infectious Diseases · 2025

A meta-analysis covering 429 studies estimated the pooled global prevalence of long COVID among people with confirmed SARS-CoV-2 infection at 36% (95% CI: 33-40%). Among eight main symptom subtypes, the most common were: respiratory complaints (20%), general fatigue (20%), psychological symptoms (18%), neurological (16%), dermatological (12%), cardiovascular (10%), musculoskeletal (9%), and gastrointestinal (5%). The authors note substantial methodological heterogeneity between primary studies — different case definitions and observation periods — which affects the wide confidence interval of this estimate.

View study

A wide spread of estimates between studies

The 36% figure from the meta-analysis above is a pooled estimate from very diverse primary studies — individual national or population studies report both clearly lower and higher values, depending on the case definition, study population (e.g., hospitalized vs. mild course), and length of observation. Treat this number as an indicative, upper order of magnitude for the problem globally, not a precise individual risk for a specific person.

The most common symptoms — not just fatigue

More than 200 different symptoms have been linked to long COVID, but a few of them dominate in most observational studies. Chronic fatigue is reported most often, frequently described as qualitatively different from ordinary tiredness — disproportionate to exertion and worsening after physical or mental activity (so-called post-exertional malaise). "Brain fog" — subjective difficulties with concentration, information processing, short-term memory, and executive function — is the second most commonly reported problem and can be especially frustrating, since it doesn't always correlate with results on standard neuropsychological tests.

Other commonly documented long COVID symptoms

  • Breathlessness and a sense of not getting enough air on exertion that previously wasn't difficult
  • Heart palpitations, intolerance to standing, and other symptoms suggestive of autonomic nervous system dysfunction (including POTS syndrome in some patients)
  • Musculoskeletal and joint pain not explained by another, known cause
  • Sleep disturbances — both insomnia and excessive sleepiness
  • Smell and taste disturbances persisting long after the acute phase of infection
  • Anxiety and depressive symptoms, partly secondary to chronic illness, and partly likely related to a direct effect of the past infection on the central nervous system

What's known about the mechanism

The mechanism of long COVID isn't yet fully explained and is most likely heterogeneous — different subgroups of patients may have different dominant pathophysiology under a shared clinical label. Hypotheses under investigation include: persistent reservoirs of the virus or its fragments in tissues outside the respiratory system, chronic immune system dysregulation and low-grade inflammation persisting after the acute infection resolves, microcirculation disturbances and microclot formation, reactivation of latent viruses (e.g., Epstein-Barr virus), and autonomic nervous system dysfunction.

Why this matters for patients

Early-stage evidence

The absence of one established mechanism means, in practice, that there isn't yet a single diagnostic test confirming long COVID, nor one therapy targeted at the cause. Diagnosis remains clinical, based on the symptom picture and exclusion of other causes — which can be frustrating for patients expecting a clear-cut blood or imaging test result.

Who's at higher risk

Factors linked to a higher risk of developing long COVID

  • A more severe course of the acute phase of infection, including hospitalization — though long COVID also occurs after a mild, outpatient course
  • Female sex — in many observational studies, women report long COVID more often than men
  • The presence of numerous symptoms already during the acute phase of infection
  • Coexisting conditions, including obesity, diabetes, and respiratory diseases
  • Lack of full vaccination before infection — some observational studies link prior vaccination with a lower risk of developing long COVID, though it doesn't eliminate it entirely
  • Prior episodes of anxiety or depression before infection

Check your profile

Constantly feeling tired?

Before reaching for random supplements, find out what's likely to matter most in your case. Answer a few questions about sleep, diet, stress, and lifestyle.

Takes about 2 minutesBased on scientific evidence

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

What actually helps — an honest review of the evidence

A key, honest piece of information: currently there is no single drug approved specifically for treating long COVID as a distinct condition. Management focuses on relieving the specific symptoms dominant in a given patient and on functional rehabilitation, rather than on one universal causal therapy.

Pharmacological and non-pharmacological management of long COVID

Early-stage evidence

literature review (collective authors) · various journals indexed in PubMed Central · 2025

Current literature reviews emphasize that most pharmacological interventions studied in long COVID (including low-dose naltrexone or NAD+ therapy) have only preliminary, limited safety and efficacy data, requiring confirmation in larger randomized trials. Functional rehabilitation with individualized, gradual dosing of exertion (pacing) — rather than classic, gradually increased exercise training, which in patients with pronounced post-exertional malaise can worsen symptoms — is currently one of the better-established elements of non-pharmacological management.

View study

Caution with classic, gradually increased exercise training

In patients with a clear post-exertional malaise component (worsening of symptoms after exertion, sometimes delayed by 24-48 hours), the standard recommendation to "gradually increase activity" can be harmful. Instead, a pacing strategy is recommended — deliberately budgeting energy and avoiding exceeding one's individual exertion tolerance threshold, ideally under the guidance of a specialist familiar with this phenomenon.

Diagnosis — what a doctor can and can't confirm

There is no single blood test confirming long COVID. Diagnosis is primarily one of exclusion — the doctor checks whether the reported symptoms (fatigue, breathlessness, heart palpitations) don't have another, identifiable and treatable cause, such as hypothyroidism, anemia, heart or lung disease, anxiety-depressive disorders, or sleep apnea. Only after reasonably excluding these alternatives, and if the time criteria are met, is post-COVID-19 condition diagnosed.

Depending on the dominant symptoms, the doctor may order additional tests — a blood count, inflammatory markers, thyroid function tests, an echocardiogram, or spirometry — not to "confirm" long COVID directly, but to rule out specific, treatable alternatives and assess the severity of individual symptoms, which matters for further rehabilitation management.

When to urgently consult a doctor

Symptoms requiring urgent evaluation

New, worsening breathlessness at rest, chest pain, fainting, significant heart palpitations with dizziness, or any symptoms suggestive of pulmonary embolism or a cardiovascular event require urgent medical evaluation — they shouldn't automatically be attributed to long COVID without first excluding directly life-threatening conditions. Long COVID is a diagnosis made after excluding more serious, alternative causes, not instead of that exclusion.

Limitations of current knowledge

What we still don't know

The lack of a uniform case definition across studies makes it difficult to compare results and precisely estimate risk. It's not yet known with certainty what proportion of cases resolve spontaneously within a year or two and what proportion persists longer — long-term data are still accumulating, since the condition itself is relatively new. Most currently studied pharmacological therapies have experimental status, and large, well-designed randomized trials are still underway — it's worth approaching skeptically private clinics offering costly, unverified "protocols" for long COVID.

QuestionShort answer
How common is long COVID?Meta-analyses estimate global prevalence at around 36% after confirmed infection, with a wide spread between studies
What are the most common symptoms?Chronic fatigue, brain fog, and breathlessness are reported most often, but over 200 different symptoms have been described
Is there an approved drug for long COVID?No — treatment is symptomatic and rehabilitative; there's no targeted therapy yet approved for this condition
Does vaccination protect against long COVID?Some observational studies link prior vaccination with lower risk, but it doesn't eliminate the risk entirely
Does intensive training help you get back in shape?Not always — in patients with worsening symptoms after exertion, standard, gradually increased training can worsen the condition; a cautious pacing strategy is recommended

Long COVID at a glance

Our editorial recommendation

Long COVID is a real clinical problem, well documented in the literature, not a "fabrication" or purely an anxiety symptom, as it was sometimes dismissed in the early years of the pandemic. At the same time, honesty toward patients requires admitting that science still doesn't have one mechanism or one therapy — which means management must be individualized, based on the dominant symptoms of a specific person, not on one universal protocol.

If you suspect you have long COVID, the most practical first step is a consultation with a doctor to rule out other, treatable causes of the symptoms — and only then, with a confirmed diagnosis, implementing individualized rehabilitation, ideally under the care of a specialist familiar with the pacing strategy, rather than experimenting on your own with intensive training or costly, unverified supplements.

The greatest harm you can do to a long COVID patient is telling them it's "just stress" — but right next to that mistake stands another: promising one miracle therapy that the current state of knowledge simply doesn't yet support.

dr Anna Kowalczyk, VitMode editorial team

Frequently asked questions

This varies greatly between individuals — some people notice clear improvement within a few months, while for others symptoms persist for a year or longer. Long-term data are still accumulating, since the condition itself is relatively new, so there aren't yet precise, established statistics on time to full resolution for all patients.

Yes, cases of long COVID have been described in children and adolescents, though research in this age group is less extensive than in adults, and the clinical picture can be somewhat different. Persistent post-infection fatigue, learning difficulties, or headaches in a child are worth reporting to a pediatrician.

Some observational data suggest that the risk of developing or worsening long COVID symptoms may accumulate with successive infections, though the exact scale of this phenomenon is still under study and isn't definitively established for every patient.

There's no single, validated diagnostic test confirming long COVID. Diagnosis is made clinically, based on the symptom picture, the time frame, and excluding other, identifiable causes of the same complaints.

There's no solid evidence that any single supplement treats long COVID as a condition. Correcting confirmed deficiencies (e.g., iron or vitamin D, if they actually occur) makes sense as part of general care, but supplementation shouldn't be treated as a therapy targeted at the cause of long COVID.

Brain fog in long COVID is described as specific difficulties with concentration, information processing, and short-term memory, often disproportionate to the subjective level of fatigue and persisting even after rest. In some patients this is confirmed by objective neuropsychological tests, though the correlation isn't always complete, which can be additionally frustrating for patients.

In patients with a post-exertional malaise component (worsening of symptoms after exertion), intensive, gradually increased training load can worsen rather than improve the condition. A safer approach is an individually tailored pacing strategy, ideally under the supervision of a specialist familiar with this phenomenon, rather than trying to "push through" fatigue by willpower alone.

These are distinct diagnoses, though they partly overlap symptomatically — some long COVID patients also meet the criteria for ME/CFS, including characteristic post-exertional malaise. However, not all long COVID patients meet ME/CFS criteria, and research into the relationship between these conditions is still ongoing.

Sources

AK

dr Anna Kowalczyk

PhD in Molecular Biology (University of Warsaw), 8 years researching cellular aging

Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.

Related articles

Dwóch mężczyzn pływających w częściowo zamarzniętym jeziorze zimą

Biohacking for Beginners — 10 Habits Worth Starting With

Before you buy your first gadget or supplement stack, start where the evidence is strongest: sleep, strength training, movement, food, and bloodwork. A practical guide to ten habits that give you the biggest return for the smallest investment.

13 min

August 20, 2026

Wygodne łóżko w sypialni oświetlone miękkim porannym słońcem

Vitamin D3 and Longevity — Does a Deficiency Shorten Your Life?

Low vitamin D levels correlate with higher mortality across dozens of observational studies, yet the massive randomized VITAL trial found no evidence that supplementation extends life in people without a deficiency. We break down this apparent contradiction piece by piece.

13 min

August 20, 2026

Kobieta śpiąca spokojnie w opasce na oczy w przyciemnionej sypialni

Sleep Biohacking — How Better Sleep Extends Your Life

Sleep tends to get treated as dead time, something to get through on the way to a productive morning. The epidemiological data says otherwise: both too little and too much sleep are linked to higher mortality risk, and sleep regularity turns out to matter more for survival than the raw number of hours. We gather what's actually known about sleep and longevity, and explain which sleep-biohacking habits actually have research behind them.

14 min

August 20, 2026

Umięśniony mężczyzna pijący odżywkę białkową z bidonu

High-Protein Diets and Kidneys: Do They Harm Healthy People?

"Too much protein wrecks your kidneys" is a warning almost everyone hears the moment they start eating more meat or protein powder. A systematic review shows higher protein intake raises glomerular filtration rate (GFR) — but that means the kidney is working harder within normal range, not that it's being damaged. There's an honest catch, though: almost no study ran longer than six months, so the truly long-term question remains open.

12 min

August 23, 2026

Related knowledge base entries

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.